Associate Professor Lenka Munoz
Head, Cell Signalling Laboratory
Charles Perkins Centre
"The known and unknown of cell signalling"
A/Prof Munoz received her PharmD (Doctor of Pharmacy, 2001) from Comenius University, Slovakia and her PhD in Medicinal Chemistry from the University of Bonn, Germany (2005). She completed her post-doctoral training in molecular pharmacology and preclinical drug development at the Northwestern University, Chicago, USA. After several years of career disruptions, she took up an appointment at the University of Sydney in 2011 as Lecturer in the Faculty of Medicine, and was promoted to Senior Lecturer in 2014 and to Associate Professor in 2017. She currently holds a Career Development Fellowship (2016-18) from the Cancer Institute NSW, and is Head of the Cell Signalling Laboratory at the Charles Perkins Centre.
A/Prof Munoz’s research is centred on cell signalling pathways and kinase inhibitors, with a particularly strong focus on kinase inhibitors for the treatment of CNS cancers. Her laboratory uses medicinal chemistry, cell biology and molecular pharmacology platforms to identify and develop novel CNS therapies. Since her PhD, she has spent 7 years FTE in research, during which time she has been awarded $3.7M in research funding, and produced 2 international patents and 27 high-quality publications in top-tier journals, e.g. Nature Reviews Drug Discovery, Journal of Medicinal Chemistry, Cancer Cell and Oncogene.